US 2003/0170216 A1Published application

SYN3 compositions and methods

AssigneeSchering-Plough Corporation

InventorsPeter M. Ihnat, Leonore C. Witchey-Lakshmanan, Varda Sandweiss, Sydney O. Ugwu

Life of this patent

Estimating the term…

Disclosed are aqueous and nonaqueous solution formulations containing agents that are useful for treating cancer.

Dependent claims

A pharmaceutical composition comprising SYN3 in combination with a pharmaceutically acceptable carrier.

Dependencies are inferred from the claim text.

A61K 31/7028
Carbohydrates; Sugars; Derivatives thereof: compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
A61K 9/0019
Galenical forms characterised by the site of application: injectable compositions; Intramuscular, intravenous, arterial, subcutaneous…
A61K 9/19
Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles: lyophilised , i.e.…
A61K 31/70
Medicinal preparations containing organic active ingredients: carbohydrates; Sugars; Derivatives thereof

From the US filing history. Foreign family members aren’t listed.

Loading patent…